Lipid [lipd]
Modulating [spco]
Drugs [phsu]
Microsomal [qlco]
Transport protein [aapp, bacs]
inhibitors [chvf]
microsomal triglyceride transfer protein [aapp, enzy]
synthesis [biof]
Very low density lipoprotein [aapp, bacs, lipd]
Deficiency [ftcn]
Abetalipoproteinaemia [dsyn]
Target [ftcn]
Assembly [acty]
secretion [biof]
Apolipoprotein B [aapp, bacs]
Containing [ftcn]
Lipoproteins [aapp, bacs]
Agent [chvf]
Play [dora]
Alone [qnco]
Combination [qlco]
treatment [ftcn]
Hypercholesterolaemia [dsyn]
Hypertriglyceridaemia [fndg]
applications [hlca]
Initially [tmco]
Focused [spco]
High dose [qnco]
Order [inpr]
reductions [npop]
Cholesterol, LDL [bacs, strd]
hepatic steatosis [dsyn]
Transaminase [aapp, enzy]
elevations [spco]
Likely [qlco]
Orphan [popg]
Indications [idcn]
risk benefit [qlco]
Profile [lbpr]
Apply [hlca]
Includes [ftcn]
Patients [podg]
Homozygous [orga]
Familial hypercholesterolaemia [dsyn]
Statins [orch, phsu]
Often [tmco]
Response [orga]
Continued [idcn]
ENTER [ftcn]
Clinical Trials [resa]
Doses [qnco]
Formulation [resa]
Efficacy [qlco]
side effects [ftcn]
promise [idcn]
Reducing [qlco]
Cholesterol [bacs, strd]
Triglycerides [bacs, lipd]
Apolipoprotein B [aapp, bacs]
Often [tmco]
Transient [popg]
side effects [ftcn]
Efficacy [qlco]
Safety [hcpp]
microsomal triglyceride transfer protein [aapp, enzy]
Inhibition [menp]
Patients [podg]
Hyperlipidaemia [dsyn]
Proven [qlco]
Clinical Endpoint [clna]
Trial [resa]
Agent [chvf]
Orphan [popg]
Indications [idcn]
Rare [tmco]
sever [topp]
Hyperlipidemias [dsyn]
